Published in Vaccine Weekly, September 1st, 2004
DVC is a CSC company.
The application was submitted on May 21, 2004 and accepted for review on July 15, 2004. Acceptance for filing indicates recognition by the FDA that the submission is complete and warrants full review of the data needed to assess the quality, safety, and efficacy of the therapeutic.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly